The aim of the study is to evaluate the benefit of the acupuncture as healing modalities
in the therapy of acute toxicity of radiotherapy.

Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors

Malignant Tumor of Soft Tissue of Head, Face and Neck

The study will enroll 100 patients in current radiotherapy of the head and neck cancer
with acute radiotoxic symptoms at least of G1. The patients will be randomized (by
ticket) in two regimens 1:1.

Regimen A (control regimen): standard support treatment of adverse events of the
radiotherapy.

Regimen B (acupuncture regimen): standard support treatment of adverse events of the
radiotherapy and acupuncture.

Due to the disease and patients differences, treatment will be individualized. Used
acupuncture points will be documented. The patients difficulties will be observed and
their medication and will be recorded in the patient diary.

Possible skin toxicities wil be documented by the photography.

Before the randomization, all subjects will sign the voluntary informed consent. After
the achievement of 50 enrolled subjects in any regimen, the enrollment will continue only
to the other regimen.

Head and neck cancer therapy will include only curative and adjuvant radiotherapy.

Acupuncture

Standard supportive therapy

Reducing the grade of acute toxicity in radiotherapy.

Lower incidence of chronic toxicity of radiotherapy.

Regimen A (control regimen): standard support treatment of adverse events of the
radiotherapy.

Regimen B (acupuncture regimen): standard support treatment of adverse events of the
radiotherapy and acupuncture.

Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status